Key Insights

Highlights

Treatment Research

4 treatments under study, led by Nasal Dilator Breath Right

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02196389Phase 4TerminatedPrimary

Comparison Between 4 Different Nasal Dilators

Showing all 1 trials

Research Network

Common Treatments

  • Nasal Dilator Breath Right1
  • Nasal Dilator Nozovent1
  • Nasal Dilator Nasanita1
  • Nasal Dilator Airmax1

Active Sponsors

  • Universitaire Ziekenhuizen KU Leuven1

Top Investigators

Activity Timeline